Contraindicated (one)pentobarbital will decrease the extent or effect of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers may end up in reduced serum concentrations and loss of antimalarial efficacy Intramuscula